Redhill Biopharma
RDHL
#10419
Rank
โ‚น0.44 B
Marketcap
โ‚น87.32
Share price
-2.34%
Change (1 day)
-79.06%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น63,670. In 2017 the company made an earnings per share (EPS) of -โ‚น2,27,394 a decrease over its 2016 EPS that were of -โ‚น2,00,106.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,27,39413.64%
2016-โ‚น2,00,1069.12%
2015-โ‚น1,83,37868.01%
2014-โ‚น1,09,149-25.93%
2013-โ‚น1,47,351

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น187.84-100.30%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น664.60-101.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น342.73-100.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น112.79-100.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น110.97-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel